SMALL CAP MOVERS: Synairgen sees boost from Covid trial
SMALL CAP MOVERS: Synairgen quadruples in value after positive data from coronavirus treatment trial By Calum Muirhead At Proactive Investors For Thisismoney Published: 12:25 BST, 24 July 2020 | Updated: 12:32 BST, 24 July 2020 A blockbuster stock on AIM this week was Synairgen, which rocketed 412 per cent higher to 189p following positive results … Read more